QuicKey Pro Human IL-6(Interleukin 6) ELISA Kit
中文名称:QuicKey Pro-人白介素6(IL-6)酶联免疫吸附测定试剂盒
别称:
Interleukin 6、IL6、BSF2、HGF、HSF、IFNB2、CDF
Price:
Size:
96T
48T
96T*5
- 反应性: Human
- 检测范围: 3.13-200 pg/mL
- 灵敏度: 1.02 pg/mL
系列介绍 | 与传统ELISA试剂盒相比,将实验时间缩短了至少1-2小时,同时提高了试剂盒的灵敏度,让客户可以获得更加精确的实验结果。该系列是Elabscience自主开发的新技术,旨在帮助客户以更为高效的方式进行科学研究。 |
用途 | 试剂盒用于体外定量检测人血清、血浆中IL-6浓度 |
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人IL-6抗体包被于酶标板上,实验时加入样品(或标准品)和辣根过氧化物酶标记的抗人IL-6检测抗体,样本(或标准品中)的人IL-6会与包被抗体及辣根过氧化物酶标记的抗人IL-6抗体结合,形成双抗体夹心的免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,IL-6浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中IL-6的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96T
/ 48T
/ 96T*5
|
反应时间 | 1.5h |
反应性 | Human |
检测方法 | Colormetric |
检测范围 | 3.13-200 pg/mL |
灵敏度 | 1.02 pg/mL |
样本体积 | 50μL |
样本类型 | 血清、血浆 |
特异性 | 可检测样本中的人IL-6,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃ |
数据处理 |
-
TLR3-/4-Priming Differentially Promotes Ca 2+ Signaling and Cytokine Expression and Ca 2+ -Dependently Augments Cytokine Release in hMSCs
IF: 5.228Journal:Scientific Reports -
Effects of circulating extracellular microvesicles from spinal cord-injured adults on endothelial cell function
IF: 5.223 -
Comparison study of Beninese and Chinese herbal medicines in treating COVID-19
IF: 5.195Journal:JOURNAL OF ETHNOPHARMACOLOGY -
A novel glyceroglycolipid from brown algae Ishige okamurae improve photoaging and counteract inflammation in UVB-induced HaCaT cells
IF: 5.194 -
Fontan protein‐losing enteropathy is associated with advanced liver disease and a proinflammatory intestinal and systemic state
IF: 5.175Journal:LIVER INTERNATIONAL -
METTL3 Promotes Activation and Inflammation of FLSs Through the NF-κB Signaling Pathway in Rheumatoid Arthritis
IF: 5.093 -
Inhibition of CREB‐mediated ZO‐1 and activation of NF‐κB‐induced IL‐6 by colonic epithelial MCT4 destroys intestinal barrier function
IF: 5.039Journal:CELL PROLIFERATION -
STING up-regulates VEGF expression in oxidative stress-induced senescence of retinal pigment epithelium via NF-κB/HIF-1α pathway
IF: 5.037 -
Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease
IF: 5.014Journal:Antioxidants -
PPAR-Alpha Agonist Fenofibrate Combined with Octreotide Acetate in the Treatment of Acute Hyperlipidemia Pancreatitis
IF: 4.964